Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Visualize vascular (slides)

211 views

Published on

Visualize:Vascular generates focused 3-D rendering from 2-D standard ultrasound images and effectively tracks the true lumen in arterial pathways. Visualize focuses on the lumen and residual lumen by essentially removing the other image content revealing a 3-D rendering of the active area through which the blood can flow. Visualize provides direct luminal measurements to calculate luminal reduction directly from ultrasound imaging.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Visualize vascular (slides)

  1. 1. Document #:600-03-00021 Rev AA
  2. 2. Salient Imaging pioneer in the development of medical imaging software algorithms  Private U.S. Corporation  Patented Technology in Imaging Algorithms  U.S. FDA certified product: Visualize:Vascular™  1st 3D rendering from 2D ultrasound focusing on the true lumen Company
  3. 3. Salient Imaging’s technology is based on proven pattern recognition principles Pattern Recognition is a well established and widely used method of identifying and classifying complex data sets  Mammography  Lung  Colon  Liver  Brain Tumor Salient Imaging applies these proven practices to medical imaging to specifically focus on ultrasound Technology
  4. 4. Salient Imaging’s technology is based on proven pattern recognition principles Pattern Recognition is a well established and widely used method of identifying and classifying complex data sets  Mammography  Lung  Colon  Liver  Brain Tumor Salient Imaging applies these proven practices to medical imaging to specifically focus on ultrasound Technology
  5. 5. Visualize:Vascular Current technology The crucial diagnostic The Salient Image shows the outside information is inside of the residual lumen of the carotid artery the carotid artery in the ICA  Find the overriding pattern  Identify the anomaly  Create focused 3D rendering  Automatically measure and calculate luminal reduction / Stenosis  Provide clinicians with focus on the salient diagnostic detail
  6. 6. Technology Works on a transverse cine clip of the artery
  7. 7. Technology Finds the lumen on each frame
  8. 8. Visualize:Vascular Technology Finds the lumen on each frame Reconstructs 3D rendering of the lumen
  9. 9. Visualize:Vascular Technology
  10. 10. Clinical Value Comparison of CDE to Visualize:Vascular to MRA • 100 consecutive cases • Any case where Visualize disagreed with Doppler or >70% on either also had MRA Key Findings: Correlation between CDE to Visualize 75% Correlation between MRA and Visualize 99% Gurell, et. al. ACR/SRU 2012 Key Findings: Correlation between CDE to Visualize 75% Correlation between MRA and Visualize 99%
  11. 11. The images to the left are from a study comparing the results of 2D Ultrasound to 3D Visualize:Vascular over the same section of the carotid artery Top Image: Ultrasound color flow can mis-lead  Measured Moderate Stenosis of 50 to 69%  Measurement is made in color block at left which is beyond the Stenosis (black)  Ultrasound data indicates patient call back in 1 yr Bottom Image: Visualize:Vascular is more accurate  Measured Severe Stenosis (85%)  Visualize data indicates immediate surgery Visualize:Vascular is Correct  Pathology confirmed that Visualize:Vascular is correct. Patient has severe amount of plaque in vessel. Clinical Significance – Shadowing
  12. 12. Ultrasound Some plaque The complete outline and extent of the plaque Visualize:Vascular Magnetic Resonance Angiography (MRA) Break Clinical Significance – Poor Fidelity The images to the right are from a case study comparing the results of 2D Ultrasound and MRA technologies to Visualize:Vascular the over the same section of artery Top Image: Ultrasound shows the outer arterial walls with limited detail of the lumen pathway, no significant plaque Middle Image: Visualize:Vascular Significant vulnerable plaque provides the most clinical detail about the region of interest Bottom Image: MRA shows that there is an occlusion by the break, but does not give specific detail Pathology confirmed results from Visualize
  13. 13. Ultrasound Velocities show 80-89% Visualize:Vascular ▪No significant concern, 52% MRA No significant concern, no break MRA confirmed results from Visualize Clinical Significance – Tortuosity
  14. 14. Ultrasound Velocities show 70-79% Visualize:Vasclar Over 80% Clinical Significance –Turbulence
  15. 15. Ultrasound Velocities show 70-79% Visualize:Vascular Over 80% Clinical Significance –Turbulence
  16. 16. Ultrasound Velocities show 70-79% Visualize:Vascular Over 80% Clinical Significance –Turbulence
  17. 17. Ultrasound Velocities show 50-69% Visualize:Vascular Significant concern, 92% CTA Significant concern, 90% CTA confirmed results from Visualize Clinical Significance – Artifact?
  18. 18. The procedure should be performed on patients who demonstrate medical necessity observed during the primary exam: Noted Presence of Plaque Noted Presence of Tortuosity Noted Presence of Artifacts: Shadowing, Speckling, Fidelity Concerns Noted Presence of Turbulent Flow Conditions Follow-up to Surgery or Interventional Procedure Medical Necessity
  19. 19. Document #:600-02-00003 Rev AA

×